Advanced pancreatic cancer: flourishing novel approaches in the era of biological therapy.
about
Genome-scale analysis identifies GJB2 and ERO1LB as prognosis markers in patients with pancreatic cancer.TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer.Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study.Allelic ratio of KRAS mutations in pancreatic cancer.
P2860
Advanced pancreatic cancer: flourishing novel approaches in the era of biological therapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Advanced pancreatic cancer: fl ...... the era of biological therapy.
@ast
Advanced pancreatic cancer: fl ...... the era of biological therapy.
@en
Advanced pancreatic cancer: fl ...... the era of biological therapy.
@nl
type
label
Advanced pancreatic cancer: fl ...... the era of biological therapy.
@ast
Advanced pancreatic cancer: fl ...... the era of biological therapy.
@en
Advanced pancreatic cancer: fl ...... the era of biological therapy.
@nl
prefLabel
Advanced pancreatic cancer: fl ...... the era of biological therapy.
@ast
Advanced pancreatic cancer: fl ...... the era of biological therapy.
@en
Advanced pancreatic cancer: fl ...... the era of biological therapy.
@nl
P2093
P2860
P1433
P1476
Advanced pancreatic cancer: flourishing novel approaches in the era of biological therapy
@en
P2093
Hilda Wong
Roberta Pang
Roland Leung
Ronnie Poon
Sheung-Tat Fan
Tan-To Cheung
P2860
P304
P356
10.1634/THEONCOLOGIST.2012-0131
P577
2014-08-12T00:00:00Z